Negative relationship between expression of glucocorticoid receptor α and disease activity: Glucocorticoid treatment of patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 37, Issue 2, 2010, Pages 316-321

  Li, Xiu ^a   Zhang, Feng Shan ^a   Zhang, Ji Hui ^a   Wang, Jing Yuan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Disease activity; Glucocorticoid receptor ; Pathogenesis; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID RECEPTOR ALPHA; MESSENGER RNA; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; WESTERN BLOTTING;

ADULT; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 76649116832     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090191     Document Type: Article

References (21)

1. Boumpas DT, Fessler BJ, Austin HA 3rd, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995;123:42-53.
2. Reichardt HM, Schütz G. Glucocorticoid signalling - multiple variations of a common theme. Mol Cell Endocrinol 1998;146:1-6.
3. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 1996;271:9550-9.
4. Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Brönneĝrd M, Wikström AC. Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 1997;272:26659-64.
5. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995;95:2435-41.
6. Bateman A, Singh A, Kral T, Solomon S. The immune-hypothalamic-pituitary- adrenal axis. Endocr Rev 1989;10:92-112.
7. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 2005;353:1711-23.
8. Jiang T, Liu S, Tan M, Huang F, Sun Y, Dong X, et al. The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis. Clin Chim Acta 2001;313:113-7.
9. Andreae J, Tripmacher R, Weltrich R, Rohde W, Keitzer R, Wahn U, et al. Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases. Pediatr Res 2001;49:130-5.
10. Eggert M, Klüter A, Rusch D, Schmidt KL, Dotzlaw H, Schulz M, et al. Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis. J Rheumatol 2002;29:2500-6.
11. Neeck G, Kluter A, Dotzlaw H, Eggert M. Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann NY Acad Sci 2002;966:491-5.
12. Van Everdingen AA, Huisman AM, Wenting MJ, van Reesema S, Jacobs JW, Bijlsma JW. Down regulation of glucocorticoid receptors in early-diagnosed rheumatoid arthritis. Clin Exp Rheumatol 2002;20:463-8.
13. Gladman DD, Urowitz MB, Doris F, Lewandowski K, Anhorn K. Glucocorticoid receptors in systemic lupus erythematosus. J Rheumatol 1991;18:681-4.
14. Tanaka H, Akama H, Ichikawa Y, Makino I, Homma M. Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy. J Rheumatol 1992;19:878-83.
15. Gehring U, Mugele K, Ulrich J. Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol Cell Endocrinol 1984;36:107-13.
16. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1987;1:68-74.
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
18. Gladman DD, Ibañez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288-91.
19. Oshima H. Studies on the glucocorticoid receptor in human peripheral lymphocytes. II. Regulation by glucocorticoid. Nippon Naibunpi Gakkai Zasshi 1986;62:1298-305.
20. Oakley RH, Cidlowski JA. Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukaryot Gene Expr 1993;3:63-88.
21. Sanden S, Tripmacher R, Weltrich R, Rohde W, Hiepe F, Burmester GR, et al. Glucocorticoid dose-dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases. J Rheumatol 2000;27:1265-70.